Table 1. The correlation between RNF43 expression and clinicopathologic characteristics of patients with clear cell renal cell carcinoma in cohort 1.
Characteristic | RNF43 | Sum (193) | P* value | |
---|---|---|---|---|
Low expression (n = 86) | High expression (n = 107) | |||
Age | 0.194 | |||
<60 | 39 | 59 | 98 | |
≥60 | 47 | 48 | 95 | |
Gender | 0.124 | |||
Male | 52 | 77 | 129 | |
Female | 34 | 30 | 64 | |
WHO/ISUP Grading | 0.070 | |||
I–II | 49 | 75 | 124 | |
III–IV | 37 | 32 | 69 | |
TNM stage | <0.001* | |||
I–II | 59 | 99 | 158 | |
III–IV | 27 | 8 | 35 | |
SSIGN | <0.001* | |||
0–4 | 65 | 101 | 166 | |
≥5 | 21 | 6 | 27 | |
YAP | <0.001* | |||
Low expression | 37 | 77 | 114 | |
High expression | 49 | 30 | 79 |
Note: *: Statistical significance was calculated by chi-square test or fisher’s exact test for categorical/binary measures.